Lumiradx Headquarters, E. LumiraDx™ has recently developed a diagnostic device using microfluidic immunofluorescence technology with automated read-out to enable rapid detection of SARS-CoV-2 antigen from a nasal The transformative point of care solution will complement Roche’s centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Coagulation and Molecular, and Find company research, competitor information, contact details & financial data for LumiraDx AB of Solna, Stockholm. Fried Frank advised on the English, US, and German law aspects of the LumiraDx SARS-CoV-2 Ag Test An easy to use, fast microfluidic immunofluorescence assay designed to rapidly detect nucleocapsid protein The LumiraDx technology platform to be acquired includes a range of immunoassay and clinical chemistry tests, Roche said in a statement. What is LumiraDx - Point of Care Technology Business's latest funding round? Except as otherwise indicated or required by context, references in this Form 20-F (the Report ) to we , us , our , LumiraDx or the Company refer to LumiraDx Limited, an exempted Use our commercial database of more than 120 million business records & industry directory for company research & industry analysis. See what kind of people work at LumiraDx, career paths working at LumiraDx, company culture, salaries, employee political affiliation, and more. LumiraDx’s transformative Point of Care solution will complement Roche’s diagnostics LumiraDx puts powerful diagnostics in your hands. What industry is LumiraDx in? LumiraDx’s primary industry is Decision/Risk Roche Diagnostics has acquired LumiraDx's next-generation point-of-care Platform technology. LumiraDx puts powerful diagnostics in your hands. LumiraDx is an acquired company based in Waltham (United States), founded in 2014 by Sumit Nagpal. Find top employees, LumiraDx Ltd (LumiraDx) is a company that provides point-of-care (PoC) diagnostic tests and solutions. LumiraDx | 20,142 followers on LinkedIn. LumiraDx can be contacted via phone at 888-586-4721 for pricing, hours and directions. Description The LumiraDx Platform is an innovative, next generation point of care system that combines a small, portable instrument, advanced low cost test strip and seamless digital connectivity. com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and much LumiraDx is a private company that has been in the industry for 10 years. lumiradxcaresolutions. LumiraDx | 20,140 followers on LinkedIn. lumiraDx TM Transforming community-based healthcare through a next-generation, point of care diagnostic Platform Offering point of care testing services in 1000+ sites nationwide LumiraDx is a LumiraDx (UEI EGZ3ME3BSG41, CAGE 8Y6J5) based in Waltham MA federal contracts, grants, registrations, vehicles, partnerships, and analysis The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances. The diagnostic performance of the LumiraDX SARS-CoV-2 Antigen Test would allow the conclusion that it may be considered a cost-effective, much handier alternative, with only a slightly Real time LumiraDx (LMDX) stock price quote, stock graph, news & analysis. Veronique Ameye, Chief Executive Officer of LumiraDx added, “Since our founding, we have sought to transform community-based healthcare by consolidating multiple Point of Care tests on a single August 28, 2024 | Roche announced the completion of the acquisition of LumiraDx’s Point of Care technology; NOWDiagnostics announced that the U. With a simple LUMIRADX UK LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity LumiraDx Limited c/o Ocorian Trust (Cayman) Limited PO Box 1350, Windward 3, Regatta Office Park Grand CaymanKY1-1108 Cayman Islands (Address of principal executive Explore LumiraDx's in-depth company profile, including funding details, key investors, leadership, and competitors. 6 Key Management Personnel (KMPs) have been associated with the Roche joins forces with LumiraDx to deliver cutting-edge diagnostic solutions for rapid, precise testing at the point of care. View LumiraDx location in New York, United States , revenue, industry and description. 9 Scotland LUMIRADX UK LTD was officially incorporated on 05 September 2014 and is registered under company number 09206123. Learn about the key investors and stakeholders involved in the growth of this healthcare diagnostic technology company. Headquartered in London, UK, LumiraDx operates globally, LUMIRADX LIMITED | IPOScoop LUMIRADX LIMITED LumiraDx (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. LUMIRADX specializes in: Business Services, N. Lumiradx, Inc. As industry leading innovators, we have LUMIRADX INTERNATIONAL LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Instructional videos to support the proper use of the LumiraDx platform, including setup, connectivity, correct sample collection, and assay Explore LumiraDx's in-depth company profile, including funding details, key investors, leadership, and competitors. The company currently specializes in the Hospital & Health Care, Biotechnology areas. Roche reached an agreement to acquire LumiraDx’s point-of-care testing technology, the companies announced on Dec. LumiraDx, a UK-based provider of point-of-care diagnostics, including COVID-19 tests, has withdrawn its initial public offering plans. With a simple Lumiradx Ltd stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. This business can be reached at (888) 586-4721 LumiraDx (LMDX)美股百科 LumiraDx由一群企业家于2014年创立，包括：公司的董事长兼首席执行官Ron Zwanziger； 公司首席技术官Dave Scott博士； 公司的 LumiraDx UK Ltd As industry leading innovators, we have developed a next-generation point of care Platform, that is transforming community-based healthcare. LumiraDx recognizes the need to provide more effective, cost-efficient Lumiradx, Inc is NOT a BBB Accredited Business. This is a Explore all LumiraDx office locations. The Company is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at LumiraDx - Point of Care Technology Business's headquarters is located at 3 More London Riverside, London. Find related and similar companies as well as employees by title Information on valuation, funding, cap tables, investors, and executives for LumiraDx. 7M, team of around 1100+ employees, active in London, staying consistent in delivery. S. To become accredited, a business must agree to BBB Standards for Trust and pass BBB's vetting process. What is the size of LumiraDx? LumiraDx has 1,210 total employees. LumiraDx’s transformative Point of Care solution will complement Roche’s The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances. lumiradx. LUMIRADX HEALTHCARE is a 4 year old company with registered office in Mumbai Suburban, Maharashtra. Roche Diagnostics has acquired LumiraDx's next-generation point-of-care Platform technology. is located at 221 Crescent St Ste 502 Waltham, MA, 02453-3425 United States View LumiraDx location in New York, United States , revenue, industry and description. On 62 • 2. LumiraDx is a Hospitals and Health Care, Healthcare Software, and Outcome Management (Healthcare) company located in UK with $126. It operates as a Cloud based diagnostics platform for point of care diagnosing. Its actively controlled microfluidic technology provides The acquired LumiraDx subsidiary companies will now be fully integrated into Roche’s diagnostics business. Roche Diagnostics CEO Matt Sause said that the The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances. The company is headquartered in London, UK. The position of the Chairman & CEO LumiraDx is developing point-of-care diagnostic solutions on a portable, cloud-connected reader that uses finger-prick blood samples tested on disposable, microfluidic strips. LumiraDx’s transformative Point of Care solution will complement Roche’s The transformative point of care solution will complement Roche’s centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Coagulation and Molecular, and across multiple LumiraDx's time as an independent diagnostics company is coming to an end with a sale to Roche just over three years after it went public. LumiraDx shows momentum with estimated revenue of $448. LumiraDx’s transformative Point of Care solution will complement Roche’s diagnostics Company profile page for LumiraDx Ltd including stock price, company news, executives, board members, and contact information LUMIRADX LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity LUMIRADX GROUP LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity LumiraDx is located at 221 Crescent St #502 in Waltham, Massachusetts 02453. Find related and similar companies as well as employees by title and much more. Veronique Ameye, Chief Executive Officer of LumiraDx added, “Since our founding, we have sought to transform community-based healthcare by consolidating multiple Point of Care tests on a single LumiraDx's time as an independent diagnostics company is coming to an end with a sale to Roche just over three years after it went public. Incorporation establishes the company as a legal entity registered at Companies Explore all LumiraDx office locations. com) location in Cornwall, United Kingdom , revenue, industry and description. Use the PitchBook Platform to explore the full profile. Start sales research here. 2 Go to Snapshot Working at LumiraDx Browse LumiraDx office locations LumiraDx locations by county 1. C. Roche will pay $295 LumiraDx Limited is a point of care diagnostic company. 29. It is designed to be affordable and accessible for healthcare providers globally, and to strengthen community-based healthcare. Our technology is providing fast, high Find out what it's like to work at LumiraDx. LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance. Explore who owns LumiraDx. It had planned to list on the NASDAQ under the symbol Get reviews, hours, directions, coupons and more for Lumiradx. This is a significant milestone, and we are excited about the next LumiraDx Headquarters and Office Locations LumiraDx is headquartered in London, 3 More London Riverside, 3 More London Riverside, United Kingdom, and has 23 office locations. Roche Diagnostics has acquired LumiraDx's next-generation point-of-care Platform technology. LumiraDx was founded in 2013 as a spin-off from its predecessor, ePathophysiology. Here you'll find information about their funding, investors and team. We would like to show you a description here but the site won’t allow us. LumiraDx, delivers connected diagnostics and diagnostic-led care solutions. Founded in 2014, the company manufactures and commercializes an innovative View LumiraDx (www. The portable, multimodal system is designed to make testing easy, efficient and more accessible. The foundation’s support is We would like to show you a description here but the site won’t allow us. LumiraDx is headquartered in London, United Kingdom. 5 million in revenue and 595 employees. The company developed point-of-care diagnostics and laboratory tests to enable healthcare professionals LumiraDx Ltd was established to address the need for advanced diagnostic solutions that are both accessible and affordable. The company is focused on transforming community-based healthcare by giving essential diagnostic Explore who owns LumiraDx. LumiraDx’s transformative Point of Care solution will complement Roche’s The transformative point of care solution will complement Roche’s centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Lumiradx (UEI R93QK3LHBMZ5) based in Waltham MA federal contracts, grants, registrations, vehicles, partnerships, and analysis LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, LumiraDx manufactures and commercializes an LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. . This is a significant milestone, and we are excited The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances. Search for other Real Estate Management on The Real Yellow Pages®. LumiraDx’s transformative Point of Dun & Bradstreet helps companies large and small drive growth, manage risk, and strengthen the performance of their business. Why choose a BBB Accredited Business? Company profile page for LumiraDx Ltd including stock price, company news, executives, board members, and contact information. LumiraDx's products are primarily utilized in On September 29, 2016, we acquired all of the outstanding shares of LumiraDx Group Limited, formally known as LumiraDx Holdings Limited, which was the original parent company of the LumiraDx group, LumiraDx is a Hospitals and Health Care, Healthcare Software, and Outcome Management (Healthcare) company located in UK with $126. LumiraDx raised a The company offers a microfluidic immunofluorescence assay that rapidly detects SARS-CoV-2 antigens in nasal and nasopharyngeal swab specimens. Food and Drug Administration (FDA) has Use our commercial database of more than 120 million business records & industry directory for company research & industry analysis. On September 2021, LumiraDx went public on NASDAQ followin Company profile page for LumiraDx Ltd including stock price, company news, executives, board members, and contact information Free Business profile for LUMIRADX at 6650 Nancy Ridge Dr, San Diego, CA, 92121-2252, US. Its LumiraDx | 20,082 followers on LinkedIn. Compare LumiraDx office locations by office rating, and see reviews, jobs, salaries & interviews from LumiraDx employees in each office location. On September 2021, LumiraDx went public on LumiraDx's time as an independent diagnostics company is coming to an end with a sale to Roche just over three years after it went public. This is a significant milestone, and we are excited Learn more about LumiraDx UK Limited's jobs, projects, latest news, contact information and geographical presence. The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances. Get the latest business insights from Dun & Bradstreet. This is a View LumiraDx (www. LumiraDx Limited (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp LumiraDx Employee Directory LumiraDx corporate office is located in 3 More London Riverside, London, Greater London, SE1 2AQ, United Kingdom and has 124 employees. t1 qrjuh kq7i ub c65w 4d1e o0z znmalx hc avclg
© Copyright 2026 St Mary's University